major depressive disorder

FDA Now Accepts Alkermes Application It Rejected Two Weeks Ago
FDA Now Accepts Alkermes Application It Rejected Two Weeks Ago
CP Wire
Alkermes
ALKS-5461
major depressive disorder
FDA
Flag link:
Alkermes' Bad News Could Be Good News for Johnson & Johnson
Alkermes' Bad News Could Be Good News for Johnson & Johnson
Motley Fool
Alkermes
JNJ
ALKS-5461
esketamine
major depressive disorder
Flag link:
Why FDA News About Alkermes ALKS 5461 Studies Is Not A Complete Surprise
Alkermes
ALKS 5461
major depressive disorder
Flag link:
FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461
FDA Rejects Alkermes NDA for Major Depressive Disorder Drug ALKS 5461
CP Wire
Alkermes
FDA
depression
major depressive disorder
ALKS 5461
Flag link:
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Sage Shares Soar Again As Depression Drug Hits Mark in Phase 2 Test
Xconomy
SAGE Therapeutics
major depressive disorder
SAGE-217
Flag link:
Will third trial be the charm for Alkermes' depression drug?
Will third trial be the charm for Alkermes' depression drug?
Fierce Biotech
Alkermes
clinical trials
ALKS 5461
major depressive disorder
Flag link:
23andMe, Lundbeck unveil mega investigation of genetics' role in depression
23andMe, Lundbeck unveil mega investigation of genetics' role in depression
BioPharma Dive
23andMe
Lundbeck
genetics
bipolar disorder
major depressive disorder
Flag link:
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Can Sage Therapeutics Press Even Further With Its Depression Trial?
Yahoo/24-7 Wall St
SAGE Therapeutics
major depressive disorder
SAGE-217
Flag link:
An Early Valuation Of Neuralstem's NSI-189 For MDD
An Early Valuation Of Neuralstem's NSI-189 For MDD
Seeking Alpha
Neuralstem
NSI-189
major depressive disorder
Flag link:
Alkermes announces advances with its late-stage CNS pipeline
Alkermes announces advances with its late-stage CNS pipeline
Yahoo/Fly on the Wall
Alkermes
aripiprazole lauroxil
schizophrenia
ALKS 5461
major depressive disorder
Flag link:
Lilly depression drug fails late-stage trial
Lilly depression drug fails late-stage trial
Yahoo/Reuters
Eli Lilly
edivoxetine
major depressive disorder
norepinephrine reuptake inhibitors
Flag link:
Alkermes depression drug gets fast track status
Alkermes depression drug gets fast track status
Bloomberg/Businessweek
Alkermes
fast track
ALKS 5461
antidepressants
major depressive disorder
Flag link:
Lundbeck, Takeda Win U.S. Approval for Depression Therapy
Lundbeck, Takeda Win U.S. Approval for Depression Therapy
Bloomberg
Lundbeck
Takeda
FDA
Brintellix
major depressive disorder
Flag link:
The Next Big Opportunity in Antidepressant Drugs
The Next Big Opportunity in Antidepressant Drugs
Motley Fool
antidepressants
Pfizer
Eli Lilly
Forest Labs
Cymbalta
Fetzima
Pristiq
major depressive disorder
Flag link:
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo
FDA
Neuralstem
NSI-189
major depressive disorder
Flag link:
FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
FDA Approves Neuralstem To Treat Second Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
Yahoo/AP
FDA
Neuralstem
NSI-189
major depressive disorder
Flag link:
Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
Forest Laboratories Submits New Drug Application for Levomilnacipran for the Treatment of Major Depressive Disorder
Enhanced Online News
levomilnacipran
major depressive disorder
biopolar depression
Forest Labs
Flag link:
Viibryd Launched by Forest Labs
Viibryd Launched by Forest Labs
Yahoo/Zacks.com
Viibryd
Forest Labs
major depressive disorder
Flag link:
Targacept, AstraZeneca begin new trial
Targacept, AstraZeneca begin new trial
Bizjournals.com
AstraZeneca
Targacept
TC-5214
major depressive disorder
Flag link:
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Clinical Data: Highly Anticipated FDA Decision Could Revive Interest
Seeking Alpha
FDA
major depressive disorder
Forest Labs
GSK
Eli Lilly
Merck
Clinical Data
Vilazodone
Pfizer
Flag link:

Pages